Polyneuropathy is a widespread, systemic condition characterized by the simultaneous damage, dysfunction, or degeneration of multiple peripheral nerves throughout the body, typically in a symmetrical and length-dependent (stocking-glove) pattern. It is distinguished from mononeuropathy (which isolates a single nerve) and plexopathy (which affects a regional network of nerves). The underlying pathological mechanisms usually involve either axonal degeneration (damage to the nerve fiber itself) or demyelination (damage to the protective myelin sheath), which disrupts electrical signaling. While it is always pathological, it can arise from diverse etiologies including metabolic insults, toxic exposures, inflammatory or autoimmune attacks, and genetic mutations. The clinically relevant subtypes most commonly encountered in coding include diabetic polyneuropathy (E11.42), alcoholic polyneuropathy (G62.1), and inflammatory polyneuropathy (G61.9). It is commonly confused with multiple mononeuropathy (mononeuritis multiplex), but the key difference is that mononeuritis multiplex involves asymmetric damage to multiple distinct nerves discontinuously, whereas polyneuropathy is typically diffuse and symmetric.
Noun-forming suffix — “disease,” “suffering or condition of”
The word entered English in the 1890s as polyneuropathy (noun), borrowed from Late Greek medical taxonomy, deriving from Greek polys, neuron, and pathos — literally “disease of many nerves.” The root neuro- (“nerve”) connects polyneuropathy to the entire -neuro family: neuropathy (disease of a nerve), neuralgia (nerve pain), and neurotoxicity (poisonous to nerves). The prefix poly- is highly productive in medical terminology, appearing in terms like polyuria, polycythemia, and polymyalgia.
🔀 ALIASES / ALTERNATE TERMS
polyneuropathic(adjective form — e.g., “polyneuropathic pain,” “polyneuropathic changes”)
peripheral neuropathy(lay and clinical synonym; broadly used in internal medicine and endocrinology, though technically polyneuropathy is a subtype of peripheral neuropathy)
axonopathy(cellular/physiologic subtype — form of the condition characterized primarily by axonal degeneration)
demyelinating polyneuropathy(cellular/physiologic subtype — form characterized by destruction of the myelin sheath)
diabetic peripheral neuropathy (DPN)(define this alias briefly and note its ICD-10-CM code — most common systemic endocrine form; E11.42)
CIDP(systemic or syndromic form — Chronic Inflammatory Demyelinating Polyneuropathy; autoimmune-related)
toxic polyneuropathy(define by cause — due to toxic agents like heavy metals, alcohol, or chemotherapy drugs)
critical illness polyneuropathy(define by cause — diffuse weakness/nerve disorder from prolonged ICU stays and systemic inflammation)
sensorimotor polyneuropathy(functional subtype — condition affecting both sensory and motor distinct nerve fibers)
small fiber polyneuropathy(anatomic subtype — preferential degeneration of A-delta and unmyelinated C fibers; often presents with severe pain and preserved reflexes)
🔗 RELATED TERMS
mononeuropathy — the opposite or singular form of polyneuropathy; localized damage to a single peripheral nerve rather than multiple, diffuse nerves.
radiculopathy — closely related clinical entity; damage occurring at the nerve root near the spinal cord rather than in the distal peripheral tracks.
Needle electromyography; one extremity with or without related paraspinal areas
95861
Needle electromyography; two extremities with or without related paraspinal areas
95863
Needle electromyography; three extremities with or without related paraspinal areas
95864
Needle electromyography; four extremities with or without related paraspinal areas
⚠️ Coding Note: For inpatient profee and hospital claims, adherence to etiology/manifestation sequencing logic is critical for polyneuropathies. When coding conditions like diabetic polyneuropathy (E11.42) or polyneuropathy due to neoplastic disease (code first the neoplasm, followed by G63), the underlying cause must dictate the primary code sequence. An undercoding alert occurs frequently with G62.9 (Polyneuropathy, unspecified): providers frequently document “generalized weakness, bilateral foot numbness, and sensory loss” linked specifically to alcohol dependence or chemotherapy, but fail to explicitly state “alcoholic polyneuropathy” or “drug-induced polyneuropathy.” This should trigger a query to link the neuropathy back to the toxic agent (upgrading to G62.1 or G62.0). Furthermore, specific CPT codes for Nerve Conduction Studies (e.g., 95907-95913) require clear documentation of the exact number of distinct nerve studies and must be supported by medical necessity showing a systemic pattern rather than a localized focal neuropathy.